Targeting MTOR may be a potential therapeutic intervention to limit the detrimental effects of inflammation during ALI, but it will be important to gain a deeper understanding of the regulatory mechanisms and cell-type-specific effects of MTOR in the lung. This evidence concerns the gene MTOR and acute respiratory distress syndrome.